The most important briefings of the day.
Karl Deisseroth, professor of bioengineering and of psychiatry and behavioral sciences, shares the news of his Nobel Prize with his kids.
King's College Hospital in London has opened a rooftop garden for critical care patients. Its first patient, a 29-year-old woman dependent on feeding tubes, said the outdoor space gave her 'a real boost to keep on going
Administration of IV iron therapy during acute infections was associated with improved 14- and 90-day survival #hematology@BloodPortfolio@CAMCHemOncIAM https://t.co/X7ad8vDvyl
#ASH25#ASHPlenary
Deciphering the dilemma: Intravenous (IV) iron use in iron deficiency anemia during acute infections
👉🏾 IV iron safe during infection and shown to improve outcome.
Dr. Haris Sohail 👏👏 Awesome job!
✅ “Yes, we can give patients IV iron while they’re getting treated for their acute infections.”
Dr. Haris Sohail @CAMCHemOncIAM on data from #ASH25, which showed IV iron significantly improved survival for iron deficiency anemia during acute infections.
https://t.co/wMBWdHd5SH
This might be the most badass brief report I’ve read in a long time.
In @NEJM
A team just published what feels like a glimpse straight into the future of cellular therapeutics: successful survival and function of transplanted allogeneic, CRISPR-edited beta cells with zero immunosuppression — in a real human with long-standing type 1 diabetes.
No anti-rejection meds.
No immune flare.
Glucose-responsive insulin secretion documented weeks after implantation.
A clean safety profile.
This is the kind of translational science that makes you think about how close we might be to rewriting what’s possible in autoimmune and metabolic disease.
Medicine is moving fast. This is one of those papers that makes you feel it.
@SamarAtta12 It was my cousin who is a mechanical engineer and he never asked for any iv abx or b12 shots. He just complied since the doctor is supposed to know what he/she is doing.